 chemotherapi invas thymoma experi patient stage iii IV invas thymoma men women median age year age chemotherapi padova medic oncolog depart all patient regimen cisplatin doxorubicin IV day vincristin IV day cyclophosphamid IV day adoc monthli interv life-threaten side effect overal clinic respons rate complet respons partial respons complet remiss median durat respons surviv month rang month month rang month seven complet remiss subsequ thoracotomi other chemotherapi combin radiat therapi second-lin treatment minim respons opinion author chemotherapi deserv evalu adjuv neo-adjuv treatment invas and/or inoper thymoma due high complet respons rate overal respons rate